This comprehensive medical resource provides South African healthcare professionals with up-to-date drug monographs, clinical guidelines, and patient education tools. It offers a medicine cost directory, interaction checker, and free accredited CPD courses to support informed decision-making at the point of care.
5.10.15
June 19, 2026
In our latest release, we have fixed some bugs and improved the general stability and performance of the app.
$119.99
Basic
Essential Newsfeed Experience
Thank you very much for your 5-star review! We are continuously working on adding more features to our app to make your experience better.
EMGuidance is a free medical app designed for South African healthcare professionals. It provides comprehensive and up-to-date information on medicines, clinical guidelines, and patient education tools to aid in point-of-care decision-making.
Yes, EMGuidance is a free resource. While it offers in-app purchases, the core functionality and access to a wide array of medicines information and clinical guidelines are available without charge.
Yes, EMGuidance contains advertisements. As a free resource, it utilizes ads to support its continued development and provision of medical information.
EMGuidance offers over 1800 interactive drug monographs, including active ingredients and pharmaceutical products. It also features a medicine cost directory and a poisons information section.
Yes, EMGuidance supports patient education by providing digital tools such as easy-to-read leaflets that can be shared with patients during consultations.
Yes, EMGuidance features a 'Learn' area with free accredited CPD courses. Users can earn and track their CPD points through a wide range of relevant content.
EMGuidance is available on iPhone, iPad, and iPod devices, making it accessible for medical professionals on the go.
The latest version of EMGuidance is 5.6.3, last updated on March 3, 2026. This indicates a commitment to providing current information, though the specific update frequency beyond this is not detailed.
